cancer doctors

The health care system in America has been set up, thanks to decades of government and private sector incentives, to be all about treatment, not prevention.

Now, Merck is feeling the effects of that mindset on preventative care with one of its drugs called Proscar, which has been proven to reduce the risk of prostate cancer.

Doctors aren't prescribing it, according to a new survey.

For the first time, cancer doctors and researchers have put the abstracts of their cancer studies online in advance of their major annual meeting later this month.

And you can bet Wall Street has been poring over the reports. Janet Babin has the story.